Abstract:Esophageal squamous cell carcinoma (ESCC) is a prevalent cancer with high morbidity and mortality worldwide. Radiotherapy is one major curative treatment modality for ESCC. Herein, our study aimed to investigate whether CAFs (cancer-associated fibroblasts), a main component of tumor microenvironment, were involved in mediating the development of radioresistance and further explored the mechanisms underlying CAFs-mediated radioresistance in ESCC. By primary culture, two pairs of CAFs and matched NFs (normal fibroblasts) had been successfully isolated from tumor tissues of ESCC patients and matched normal esophageal epithelial tissues, respectively. The secretion of chemokines by CAFs and matched NFs was determined by the human chemokine antibody array. The concentrations of chemokine in culture medium of CAFs, matched NFs and ESCC cells were determined by Elisa assay. The effect of CAFs-secreted chemokines on radioresistance was investigated in vitro by clonogenic survival assay, detection of DNA double-strand breaks (DSBs) and by flow cytometry analysis on cell apoptosis. By establishment of xenograft tumor models in BALB/c nude mice, the effect of CAFs on radioresistance was investigated in vivo. CAFs conferred ESCC cells KYSE-30 and KYSE-150 significant radioresistance by promoting clonogenic survival and inhibiting DSBs and cell apoptosis following radiation in comparison with their matched NFs. Mechanism studies revealed that human chemokine CXCL1 (The chemokine [C-X-C motif] ligand 1) was secreted by CAFs at a significantly higher level compared with matched NFs and ESCC cells. Inhibition of CXCL1 expression in CAFs by the human specific antibody against CXCL1 significantly reversed CAFs-mediated radioresistance by enhancing radiation-induced DSBs, and inhibiting DNA damage repair response and the activation of anti-apoptotic Mek/Erk signaling pathway. The use of CXCL1 antibody also significantly reversed CAFs-mediated radioresistance in xenograft tumor models. Further studies demonstrated that CAFs-secreted CXCL1 suppressed the expression of antioxidant enzyme SOD1 (superoxide dismutases), leading to accelerated ROS (Reactive Oxygen Species) accumulation which activated DNA damage repair response and mediated the radioresistance. Moreover, the crosstalk of CAFs and ESCC cells induced CXCL1 expression in an autocrine/paracrine signaling loop by which the radioresistance was further enhanced. Our study for the first time discovered CAFs-secreted CXCL1 as an attractive target to reverse the radioresistance of ESCC.

Calcium Channel Alpha 2 Delta 1 Subunit (Cacna2d1) Enhances Radioresistance In Cancer Stem-Like Cells In Non-Small Cell Lung Cancer Cell Lines

P2.05-002 CACNA2D1 Enhances Radio-Resistance in Cancer Stem-Like Cells in NSCLC

AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

Data from Integrative Analysis Identifies a Novel AXL–PI3 Kinase–PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer

GLUT-1 Sirna Enhances Radiosensitization of Laryngeal Cancer Stem Cells Via Enhanced DNA Damage, Cell Cycle Redistribution, and Promotion of Apoptosis in Vitro and in Vivo.

Data from Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel Α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines.

TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells

Calcium channel α2δ1 subunit is a functional marker and therapeutic target for tumor-initiating cells in non-small cell lung cancer

Radiosensitization of Clioquinol Combined with Zinc in the Nasopharyngeal Cancer Stem-Like Cells by Inhibiting Autophagy in Vitro and in Vivo

Voltage-Dependent Calcium Channel Alpha 2 Delta 1 Subunit Is A Specific Candidate Marker For Identifying Gastric Cancer Stem Cells

Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin

Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells

Radiotherapy Sensitization by Tumor-Specific TRAIL Gene Targeting Improves Survival of Mice Bearing Human Non–Small Cell Lung Cancer

Elevated expression of Nrf2 mediates multidrug resistance in CD133+ head and neck squamous cell carcinoma stem cells

Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench

CAFs-Secreted CXCL1 Mediated Radioresistance by Regulating DNA Damage Response in an ROS-Dependent Manner in Esophageal Squamous Cell Carcinoma

Inhibition of DNA-PKcs Enhances Radiosensitivity and Increases the Levels of ATM and ATR in NSCLC Cells Exposed to Carbon Ion Irradiation.

AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage

Prognosis biomarker and potential therapeutic target CRIP2 associated with radiosensitivity in NSCLC cells

Targeting the dendritic cell-secreted immunoregulatory cytokine CCL22 alleviates radioresistance